Cybin (HELP) Amortizatization of Intangibles (2020 - 2022)
Cybin (HELP) reported Amortizatization of Intangibles of $521193.2 for Q1 2022, up 1013.5% quarter-over-quarter from $46806.8 in Q4 2021.
Cybin (HELP) Amortizatization of Intangibles (2020 - 2022) Analysis & Trends
Cybin has reported Amortizatization of Intangibles for 3 years, with the latest figure at $521193.2 in Q1 2022.
- For the quarter ending Q1 2022, Amortizatization of Intangibles changed N/A year-over-year to $521193.2; the trailing twelve-month figure through Dec 2022 stood at $568000.1 (up 143.37% YoY), and the FY2023 full-year result was -$284065.6, down 195.46% from the prior year.
- Amortizatization of Intangibles for Q1 2022 stood at $521193.2, up from $46806.8 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $521193.2 in Q1 2022, with the low at $7212.0 in Q2 2020.
- Historically, Amortizatization of Intangibles has averaged $152359.7 across 3 years, with a median of $55608.7 in 2021.
- The largest YoY upside for Amortizatization of Intangibles was 1716.1% in 2021 against a maximum downside of 1716.1% in 2021.
- Cybin's Amortizatization of Intangibles stood at $7212.0 in 2020, then soared by 549.01% to $46806.8 in 2021, then jumped by 1013.5% to $521193.2 in 2022.
- The last three Amortizatization of Intangibles figures came in at $521193.2 (Q1 2022), $46806.8 (Q4 2021), and $55608.7 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2022 | 521,193.22 |
| Feb 28, 2022 | 521,193.22 |
| Dec 31, 2021 | 46,806.83 |
| Dec 31, 2021 | 46,806.83 |
| Sep 30, 2021 | 55,608.65 |
| Sep 30, 2021 | 55,608.65 |
| Jun 30, 2021 | 130,977.87 |
| Jun 30, 2021 | 130,977.87 |
| Jun 30, 2020 | 7,212.04 |
| Jun 30, 2020 | 7,212.04 |